Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/10009
|
Title: | Beta1 integrin as a prognostic and predictive marker in triple-negative breast cancer |
Other Titles: | β1 integrin as a prognostic and predictive marker in triple-negative breast cancer |
Authors: | Yin, HL;Wu, CC;Lin, CH;Chai, CY;Hou, MF;Chang, SJ;Tsai, HP;Hung, WC;Pan, MR;Luo, CW |
Contributors: | National Institute of Cancer Research |
Abstract: | Triple negative breast cancer (TNBC) displays higher risk of recurrence and distant metastasis. Due to absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), TNBC lacks clinically established targeted therapies. Therefore, understanding of the mechanism underlying the aggressive behaviors of TNBC is required for the design of individualized strategies and the elongation of overall survival duration. Here, we supported a positive correlation between beta1 integrin and malignant behaviors such as cell migration, invasion, and drug resistance. We found that silencing of beta1 integrin inhibited cell migration, invasion, and increased the sensitivity to anti-cancer drug. In contrast, activation of beta1 integrin increased cell migration, invasion, and decreased the sensitivity to anti-cancer drug. Furthermore, we found that silencing of beta1 integrin abolished Focal adhesion kinese (FAK) mediated cell survival. Overexpression of FAK could restore cisplatin-induced apoptosis in beta1 integrin-depleted cells. Consistent to in vitro data, beta1 integrin expression was also positively correlated with FAK (p = 0.031) in clinical tissue. More importantly, beta1 integrin expression was significantly correlated with patient outcome. In summary, our study indicated that beta1 integrin could regulate TNBC cells migration, invasion, drug sensitivity, and be a potential prognostic biomarker in TNBC patient survival. |
Date: | 2016-09 |
Relation: | International Journal of Molecular Sciences. 2016 Sep;17(9):Article number 1432. |
Link to: | http://dx.doi.org/10.3390/ijms17091432 |
JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1422-0067&DestApp=IC2JCR |
Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000385525500059 |
Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85016089903 |
Appears in Collections: | [洪文俊] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
PUB27589736.pdf | | 5955Kb | Adobe PDF | 425 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|